recurrent aphthous ulcers. Recurrent oral aphthae
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with minor aphthous lesions less than 2 days from initiation The individuals who had not suffered from systemic diseases or immunologic disease The patient should not receive other concurrent medication for aphthous ulcers either systematically or locally at the same time with this medicine Patients who had a history of frequent recurrence of aphthous lesions The occurrence of aphthous lesions is not caused by beta blockers and NSAIDs Patients who dose not being in pregnancy or breastfeeding time Patients who have not been receiving Anti-inflammatory or immunosuppressive drugs for at least 2 weeks before the study begins Patients who have not been receiving systemic Antibiotics for at least 2 weeks before the study begins Have not treated aphthous ulcers with any other medicine in the last 3 days Patients who have not been receiving sedative medicine for other diseases
Exclusion criteria
Exclusion criteria: In case of sudden problem or violation of Inclusion criteria, the patient will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of lesion's pseudomembrane removing. Timepoint: The time when the pseudomembrane and the erythematous border are removed. Method of measurement: Observing the lesion.;The size of the lesion. Timepoint: The aphthous lesion size will be recorded on days 0, 1, 3, and 5. Method of measurement: Periodontal probe.;The aphthous pain level. Timepoint: The patients are asked to record the aphthous pain level on days 0, 1, 3, and 5. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences